MTA2 and Alzheimer disease: Recent groundbreaking cryo-EM structures of tau filaments from patients with AD, PiD, and CBD further provided atomic evidence of different molecular conformers for several distinct neurodegenerative tauopathies (Fitzpatrick et al., 2017; Falcon et al., 2018; Zhang et al., 2020).